From the seeds of Carum copticum thymol (1) was isolated as the major component and ten derivatives (2-11) were prepared by reacting it with different acid chlorides in a single step. They were evaluated for antimicrobial activity against twelve bacterial strains and nine fungal strains using disc diffusion and broth dilution assays. Derivative 9 was found to be most active against both bacterial and fungal strains.
Thymol (1) is extensively used as an oral and/or intestinal antiseptic as such and after hydrogenation to menthol [3] . It is a phenolic monoterpene that is a major constituent of the essential oil of Oliveria decumbens [4] , Ocimum gratissimum [5] , Lippia sidoides [6] and Carum copticum. It has been credited with a series of pharmacological properties that include antimicrobial [6] , anti-inflammatory [7] and antioxidant [8] . It has shown inhibitory activity on the adhesion to human vaginal cells of E. coli and S. aureus [9] . It is evident that 1, in free form as well as in formulations with other monoterpenes, is a good inhibitor of pathogens responsible for 'toe nail fungus' [10] . 1 is a scavenger of various reactive oxygen species (ROS) and has protective activity against carbon tetrachloride-induced hepatoxicity [11] . Introduction of Mannich bases to phenolic compounds is accompanied by increased bioactivity, including cytotoxic, antimicrobial and cardiovascular activities [12] . Several natural and a few synthetic derivatives of 1 are known and their spectral data have been reported in the literature [13] . Although they have been explored for many pharmacological activities, none of the derivatives has yet become a therapeutic lead.
Natural products have recently been investigated more thoroughly as promising agents for control of microbes. The increasing resistance to available antimicrobials has attracted the attention of the scientific community regarding the search for new cost-effective drugs of natural and synthetic origin. Essential oils in general demonstrate antimicrobial activity against cariogenic microbes and fungal filaments. Compound 1, being a good candidate for such a target antimicrobial drug, has been taken for further study.
The aim of the present study was to synthesize derivatives of thymol by reacting it with acid chlorides under varying conditions and to investigate the activity of the products against twelve bacterial strains and nine fungal strains.
Thymol (1) has a phenolic group attached at C-3 which is susceptible to electrophilic attack. Here, the electrophiles used were different acid chlorides, which formed esters of thymol under basic conditions, although in a few cases ester formation took place under neat conditions. 1 was reacted with p-anisoyl chloride and triethylamine (TEA), the latter used to maintain mild basic conditions, to furnish 2 in 89% (w/w) yield. Similarly, 3, 5, 7, 8, 10 and 11 were synthesized in a single step in quantitative yields. 10 and 11 were synthesized under reflux conditions, as the reaction at room temperature failed to give above 50% yield, after stirring all night. Synthesis of 4, 6 and 9 took place under neat conditions, without any basic catalyst. The structures of the derivatives were confirmed from FT-IR, 1 H and 13 C NMR spectroscopic and FAB-MS data.
Formation of the ester linkage was confirmed by the presence of a peak at δ163-172 in the 13 C NMR spectra of all the compounds, except 6 as it was an ether derivative. In the 1 H NMR spectra, the broad singlet at δ 4.77 for OH disappeared, and new peaks appeared for the side-chain attached. There was a sharp absorption band at 1728 cm -1 in the IR spectrum of 2, which further confirmed the above 
* same for all the three phenyl rings; J values are in Hz (2) - (7) - (10) - (2) - fact. In the IR spectrum, there was a strong absorption band around 1100 cm -1 , so it was clear that the phenolic group had been modified to either an ester or ether side chain. These facts were well supported by the mass spectra of the derivatives. The complete peak assignments of the 1 H and 13 C NMR spectra of compounds 1-11 are listed in Tables 1 and 2. Compounds 1-11 were screened for their antimicrobial activity against twelve bacterial and nine fungal strains. From the activity results, it was evident that 1 is a good antibacterial and a moderate antifungal agent. 1, at a dose of 50 µg/disc, produced a zone of growth inhibition greater than 10 mm against SM, MS, SE and YE, which is greater than that produced by the standard, Tetracycline, at a dose of 30 µg/disc against these species of pathogens. With such a low Minimum Inhibitory Dilution (MID) factor, it is effective in inhibiting the growth of active bacteria. Among the derivatives, 2, 4, 5, 7, 8, 10 and 11 were found to be inactive against all bacterial strains, while 3 and 6 inhibited the growth of some strains to a few millimeters, but 9 was the most active derivative against all strains, except KP; 9 was comparatively more active than thymol and Tetracycline. 1 did not show good inhibition of fungal strains at the concentrations used. It inhibited the growth of AF by 15 mm on the disc, but for the other strains the inhibition was moderate. All the derivatives were inactive except 9, which was more effective than thymol against all strains, particularly HC and AF. The complete activity data are compiled in Tables 3 and 4 .
Conclusion
Conversion of the phenolic group of thymol to either an ester or ether in general reduced its activity. All the derivatives 2-11, except 9, showed either no activity or moderate activity against pathogenic bacteria and fungus, in comparison to 1. Compound 9, however, showed good inhibitory action towards both bacteria and fungus. Thus this compound can be used in antimicrobial formulations as either a major constituent or in combination with other antimicrobial agents. This study will provide a good lead to researchers working in this field.
Experimental
General: All the reactions were carried out at room temperature unless mentioned. All the solvents used were distilled prior to use. Acid chlorides and other reagent used were bought from Sigma Aldrich. 1 
Essential oil extraction and isolation of thymol:
Dried crushed seeds of C. copticum were hydrodistilled on a Clevenger type apparatus for 6 h. The yield of oil obtained was 4.85%. The oil was kept in a freezer, which led to crystallization of thymol, which was then removed by filtration; the crystals were obtained by passing the crystallized portion through a sintered funnel and colorless pure crystals were obtained. The purity was 97% (GC). The identity was confirmed by Co-TLC using an authentic sample, and from spectral data.
Microbial strains and media:
The bacterial and fungal strains used and their origins are given in Tables 3 and 4 , respectively. The bacterial and fungal cultures were raised on Mueller-Hinton (Hi-Media) agar and Sabouraud dextrose (Hi-Media) agar media, respectively. Bacterial cultures were grown at 37ºC and fungal cultures at 28ºC. Streptococcus mutans was grown on brain heart infusion agar at 28ºC.
Disk diffusion assay (i) Antibacterial activity testing:
This was conducted by the method of Bauer et al [14] . All bacteria were subcultured from -80ºC stock cultures into 5 mL Mueller-Hinton broth and incubated for 24 h at 37ºC. For use as an inoculum, the turbidity of the bacterial suspension was adjusted to the McFarland standard 0.5 (ca.2-4 x 10 6 cfu/mL). Bacterial culture (0.1 mL) was spread plated onto the solid agar medium and paper discs (5 mm diameter) impregnated with test compound were placed on the pre-inoculated agar surface. Observations were recorded after 48 h of incubation of the plates at the desired temperatures.
(ii) Antifungal activity testing: This utilized the method of Wannisorn et al [15] . Fungal cultures were grown on SDA at 28ºC for seven days. Suspension of each fungus was prepared in 0.85% normal saline containing 0.1% Tween 80. For use as inoculum, the turbidity of the fungal suspensions was also adjusted to the McFarland standard 0.5. A seeded agar plate was prepared by pouring (a) 20 mL of SDA into a sterile plate and, (b) uniformly overlying of the solid medium with 5 mL of soft agar, pre-inoculated with 0.1 mL of fungal suspension. Each of the test compounds was diluted / dissolved in DMSO to the required concentration and applied onto filter paper discs (diameter 5 mm) at 50µg / disc. The discs were transferred onto the surface of seeded agar plates (1disc/plate) and gently pressed down to ensure contact. The plates were incubated at 28ºC for 3 days in the case of yeasts strains and for 7-10 days for mycelial fungi after which time the zone of growth inhibition was measured.
Broth dilution assay:
A two-fold serial dilution technique was employed to assess the minimum inhibitory dilution (MID) of a given component in a series of 2 mL screw cap tubes. The test component was diluted directly into the Saboauraud Dextrose Broth (SDB) containing 0.08% Tween-80 and solubilized by vigorous vortexing for 3 min. Fungal inoculum (0.01 mL), prepared as before, was inoculated into each tube (ca. 2-6x10 5 spores/mL). The MID was taken as the lowest dilution of the test compound that inhibited the appearance of visible growth.
Thymyl-p-anisoylate (2): Thymol (1 g) and panisoyl chloride (1.2 mL) were stirred in DCM, and then TEA (0.5 mL) was added to them. Stirring continued until completion of the reaction, as checked by TLC. The reaction mixture was washed with distilled water (10 mL x 3), dried over anhy. MgSO 4 and then conc to yield 1.5 g crude product.
The crude product was subjected to CC on Si-gel with n-hexane as eluent, which furnished 2, as a colorless oil (yield: 89.0%). Thymyl laurate (5) : The procedure was same as that used for 2, using lauryl chloride (1.5 mL).The crude mass was purified by CC on Si-gel to give colorless solid 5 (yield: 90.0%). Thymyl tritylate (6): 1 (1.0 g) and trityl chloride (1.0 g) were mixed and left at room temperature overnight. After purification by CC, 6, was obtained as a colorless solid (yield: 97.0%).
MP

